Keith Klein

Keith Klein is a declared insider of Kythera Biopharmaceuticals Inc, with filings sourced from SEC (Form 4). We count 23 filings; the first trade dates from 1 May 2013 and the latest from 1 October 2015.

No open-market purchase appears, only 9 sales worth €4.6M. Other entries cover 1 share grant and 11 option exercises. Since January 2015: no purchases and 5 sales on the market.

The newest entry dates from 2 October 2015: a transaction, in Kythera Biopharmaceuticals Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. US insiders must file a Form 4 within two business days of a trade. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.